These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27256047)

  • 1. [Comparison of HER2 gene status between primary breast cancer and synchronous axillary lymph node metastasis].
    Liu YY; Wu SF; Liang ZY; Zeng X
    Zhonghua Bing Li Xue Za Zhi; 2016 Jun; 45(6):393-6. PubMed ID: 27256047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Case to Case Comparison of Hormone Receptors and HER2 Status between Primary Breast Cancer and Synchronous Axillary Lymph Node Metastasis.
    Sujarittanakarn S; Himakhun W; Worasawate W; Prasert W
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1559-1565. PubMed ID: 32592349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative genic switch of HER-2 in the primary tumor instead of the synchronous metastatic nodal lesions after neoadjuvant chemotherapy in a patient with primary HER2-positive breast cancer.
    Chen HR; Wu YT; Yu QB; Yang YY; Wei YX; Li HY; Wu KN; Kong LQ
    World J Surg Oncol; 2017 Oct; 15(1):189. PubMed ID: 29052527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HER2 gene status and mRNA expression in immunohistochemistry 1+ breast cancer].
    Wu SF; Liu YY; Liu XD; Jiang Y; Luo YF; Cui QC; Liang ZY; Zeng X
    Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):522-526. PubMed ID: 29996317
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormone Receptor Status and HER2 Expression in Primary Breast Cancer Compared With Synchronous Axillary Metastases or Recurrent Metastatic Disease.
    Rossi S; Basso M; Strippoli A; Dadduzio V; Cerchiaro E; Barile R; D'Argento E; Cassano A; Schinzari G; Barone C
    Clin Breast Cancer; 2015 Oct; 15(5):307-12. PubMed ID: 25922284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Internodal HER2 heterogeneity of axillary lymph node metastases in breast cancer patients.
    Baroš IV; Tanasković N; Pellas U; Eri Ž; Tadić Latinović L; Tot T
    Bosn J Basic Med Sci; 2019 Aug; 19(3):242-248. PubMed ID: 30957723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordance and clinical significance of ER, PR, and HER2 status between primary breast cancer and synchronous axillary lymph node metastasis.
    Yao ZX; Lu LJ; Wang RJ; Jin LB; Liu SC; Li HY; Ren GS; Wu KN; Wang DL; Kong LQ
    Med Oncol; 2014 Jan; 31(1):798. PubMed ID: 24307349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordance Rate in Estrogen Receptor, Progesterone Receptor, HER2 Status, and Ki67 Index Between Primary Unifocal and Multiple Homogenous Breast Carcinomas and Synchronous Axillary Lymph Node Metastases Have an Impact on Therapeutic Decision.
    Georgescu R; Boros M; Moncea D; Bauer O; Coros MF; Oprea A; Moldovan C; Podoleanu C; Stolnicu S
    Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):533-538. PubMed ID: 28099174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison Between HER2, Estrogen Receptors and Progesterone Receptors in Primary Breast Carcinomas and Matched Lymph Node Metastases.
    Desouki MM; Atta IS; Wolff DJ; Self SE
    Turk Patoloji Derg; 2016; 32(3):178-85. PubMed ID: 27562392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of HER2/neu gene amplification and its protein overexpression between primary breast cancer and metastatic lymph nodes.
    Aoyama K; Kamio T; Nishikawa T; Kameoka S
    Jpn J Clin Oncol; 2010 Jul; 40(7):613-9. PubMed ID: 20202990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER-2 status discrepancy between primary breast cancer and metastatic sites. Impact on target therapy.
    Santinelli A; Pisa E; Stramazzotti D; Fabris G
    Int J Cancer; 2008 Mar; 122(5):999-1004. PubMed ID: 17973263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of HER2 gene amplification in breast cancer: a comparison of dual-color in-situ hybridization and fluorescence in-situ hybridization].
    Xu Y; Yang W; Yang F; Lu Y; Cai X; Zhou X
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):226-30. PubMed ID: 24915811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concordance Between FISH Analysis of Her-2/Neu Gene in Breast Duct Carcinoma and Corresponding Axillary Nodal Metastases: Egyptian National Cancer Institute Experience.
    Badawy OM; Hassan H; ELBakey HA; Mosaad M
    Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):295-300. PubMed ID: 29750667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is her-2 status in the primary tumor correlated with matched lymph node metastases in patients with gastric cancer undergoing curative gastrectomy?
    Selcukbiricik F; Erdamar S; Buyukunal E; Serrdengecti S; Demirelli F
    Asian Pac J Cancer Prev; 2014; 15(24):10607-11. PubMed ID: 25605147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordance rate of HER2 status in primary breast carcinomas versus synchronous axillary lymph node metastases: a multicenter retrospective investigation.
    Ieni A; Barresi V; Caltabiano R; Cascone AM; Del Sordo R; Cabibi D; Zeppa P; Lanzafame S; Sidoni A; Franco V; Tuccari G
    Onco Targets Ther; 2014; 7():1267-72. PubMed ID: 25050068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of factors influencing the axillary lymph node metastasis and breast cancer-specific survival in patients with T1 breast cancer].
    Jiao DC; Qiao JH; Zhu JJ; Wang LN; Ma YZ; Lu ZD; Liu ZZ
    Zhonghua Yi Xue Za Zhi; 2018 Oct; 98(40):3258-3262. PubMed ID: 30392292
    [No Abstract]   [Full Text] [Related]  

  • 17. Could the Breast Prognostic Biomarker Status Change During Disease Progression? An Immunohistochemical Comparison between Primary Tumors and Synchronous Nodal Metastasis.
    El Nemr Esmail RS; El Farouk Abdel-Salam LO; Abd El Ellah MM
    Asian Pac J Cancer Prev; 2015; 16(10):4317-21. PubMed ID: 26028092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer.
    Jensen JD; Knoop A; Ewertz M; Laenkholm AV
    Breast Cancer Res Treat; 2012 Apr; 132(2):511-21. PubMed ID: 21667123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessment and significance of human epidermal growth factor receptor 2 gene status in breast cancer with polysomy of chromosome 17].
    Zhang H; Si JW; Zhang S; Wang Y; Li D; Li T
    Zhonghua Zhong Liu Za Zhi; 2016 Feb; 38(2):124-9. PubMed ID: 26899332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of using the cell block method to determine the discordance of the HR/HER2 expression in patients with metastatic breast cancer.
    Nakayama Y; Nakagomi H; Omori M; Inoue M; Takahashi K; Maruyama M; Takano A; Furuya K; Amemiya K; Ishii E; Oyama T
    Breast Cancer; 2016 Jul; 23(4):633-9. PubMed ID: 25968348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.